AS
Adi Sesha Giri Jagarapu
About Adi Sesha Giri Jagarapu
Data last updated:
Adi Sesha Giri Jagarapu has 6 years in corporate governance. Holds Director role. Currently with 3 companies, including Hetero Drugs Limited and Ojas Pharmaceuticals Private Limited. Formerly with 1 company, such as Degradable Polymer Technologies Private Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Hetero Drugs Limited U24230TG1993PLC015582 | Director | 23 Sep 2021 | 1993 | Active |
 Ojas Pharmaceuticals Private Limited U24230TG1993PTC016508 | Director | 22 Jun 2020 | 1993 | Active |
 Honour Lab Limited U24233TG2011PLC077561 | Director | 18 Dec 2023 | 2011 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Degradable Polymer Technologies Private Limited U25200TG2010PTC070541 | Additional Director | 22 Jun 2020 | 2010 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Adi Sesha Giri Jagarapu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Adi Sesha Giri Jagarapu
Adi Sesha Giri Jagarapu has 6 years in corporate governance. Holds Director role. Currently with 3 companies, including Hetero Drugs Limited and Ojas Pharmaceuticals Private Limited. Formerly with 1 company, such as Degradable Polymer Technologies Private Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Adi Sesha Giri Jagarapu is associated with 3 companies as Director.
Adi Sesha Giri Jagarapu has expertise in General Business, Technology.
Adi Sesha Giri Jagarapu has 6 years in corporate governance.